Clinical Trial Update: The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating local vaginal estrogen for postmenopausal pelvic organ prolapse (with vaginal atrophy) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse
• Vaginal Atrophy

Drugs mentioned

• Local vaginal estrogen (estradiol)

Snippet

Sponsor: TriHealth Inc. | Conditions: Pelvic Organ Prolapse, Vaginal Atrophy | Phase 3 | Status: COMPLETED